Clinical Trials
8 trialsNCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
NCT05131841 2021-11-23
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Zhejiang Cancer Hospital
Phase 4 Unknown
NCT03270007 2020-10-28
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
Peking University
Phase 4 Unknown
NCT01848613 2018-11-09
VIVOS
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 4 Completed
NCT00372476 2017-02-07
INV181
Novartis
Phase 4 Completed
NCT01196078 2015-07-27
A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed